Sex steroids and changes in the cardiovascular system: Carbohydrate metabolism

References

• Després J.-P., Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr. Opin. Lipidol. 1994; 5: 274–89
   PubMedGoogle Scholar
• Reaven G. M., Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 1994; 37: 948–52
   PubMed Web of Science ®Google Scholar
• Godsland I. F., Stevenson J. C. Insulin resistance: syndrome or tendency. Lancet 1995; 346: 100–3
   PubMed Web of Science ®Google Scholar
• Spellacy W., Carlson K. Plasma insulin and blood glucose levels in patients taking oral contraceptives. Am. J. Obstet. Gynecol. 1966; 95: 474–9
   PubMed Web of Science ®Google Scholar
• Wynn V., Doar J. Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966; 2: 715–19
   PubMed Web of Science ®Google Scholar
• Ruderman N. B., Haudenschild C. Diabetes as an atherogenic factor. Prog. Cardiovasc. Dis. 1984; 26: 373–411
   PubMedGoogle Scholar
• Schwartz C. J., Valente A. J., Sprague E. A., Kelley J. L., Cayatte A. J., Rozek M. M. Pathogenesis of the atherosclerotic lesion: implications for diabetes mellitus. Diabetes Care 1992; 15: 1156–67
   PubMed Web of Science ®Google Scholar
• Pyorälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart dlsease: results from two population studies in Finland. Diab. Metab. 1979; 13: 345–9
   Google Scholar
• Welborn T., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2: 154–60
   PubMedGoogle Scholar
• Ducimetiere P., Eschwège E., Papoz L., Richard J., Claude J., Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease in a middle-aged population. Diabetologia 1980; 19: 205–10
   PubMed Web of Science ®Google Scholar
• Stout R. Insulin and atheroma: 20-yr perspective. Diabetes Care 1990; 13: 631–54
   PubMed Web of Science ®Google Scholar
• Fontbonne A., Charles M. A., Thibult N., Richard J. L., Claude J. R., Warnet J. M., Rosselin G. E., Eschwège E. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia 1991; 34: 356–61
   PubMed Web of Science ®Google Scholar
• Stem M. P. The insulin resistance syndrome: the controversy is dead, long live the controversy!. Diabetologia 1994; 37: 956–8
   Google Scholar
• McKems K., Coulomb B., Kaleita E., DeRenzo E. Some effects of in vivo administered oestrogens on glucose metabolism and adrenal cortical secretion in vitro. Endocrinology 1958; 63: 709–22
   Google Scholar
• Rushakoff R., Kalkhoff R. Effects of pregnancy and sex steroid administration on skeletal muscle metabolism in the rat. Diabetes 1981; 30: 545–50
   PubMedGoogle Scholar
• Talaat M., Habib Y., Higazy A., AbdelNaby S., Malek A., Ibrahim Z. Effects of sex hormones on the carbohydrate metabolism in normal and diabetic women. Arch. Int. Pharmacodyn. 1965; 54: 402–11
   Google Scholar
• Silfverstolpe G., Gustafson A., Samsioe G., Svanborg A. Lipid metabolic studies in oophorectomised women: effects induced by two different estrogens on serum lipids and lipoproteins. Gynecol. Obstet. Invest. 1980; 11: 161–9
   PubMedGoogle Scholar
• Notelovitz M., Johnson M., Smith S., Kitchens C. Metabolic and hormonal effects of 25 mg and 50 mg 17β-estradiol implants in surgically menopausal women. Obstet. Gynecol. 1987; 70: 749–54
   PubMed Web of Science ®Google Scholar
• Cagnacci A., Soldani R., Carriero P., Paoletti A., Fioretti P., Melis G. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women. J. Clin. Endocrinol. Metab. 1992; 74: 1396–400
   PubMed Web of Science ®Google Scholar
• Lindheim S. R., De D. M., Kojima T., Vijod M. A., Stancxyk F. Z., Lobo R. A. The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil. Steril. 1994; 62: 1176–80
   Google Scholar
• O'Sullivan A. J., Ho K. K.Y. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J. Clin. Endocrinol. Metab. 1995; 80: 1783–8
   PubMed Web of Science ®Google Scholar
• Pyorälä K., Pyorälä T., Lampinen V. Sequential oral contraceptive treatment and intravenous glucose tolerance. Lancet 1967; 2: 776–7
   Google Scholar
• Javier Z., Gershberg H., Hulse M. Ovulatory suppressants, estrogens and carbohydrate metabolism. Metabolism 1968; 17: 443–56
   PubMed Web of Science ®Google Scholar
• Goldman J., Ovadia J. The effect of estrogen on intravenous glucose tolerance in women. Am. J. Obstet. Gynecol. 1969; 103: 172–8
   Google Scholar
• Yen S., Vela P. Carbohydrate metabolism and long term use of oral contraceptives. J. Reprod. Med. 1969; 3: 25–37
   Google Scholar
• DiPaola G., Robin M., Nicholson R. Estrogen therapy and glucose tolerance test. Am. J. Obstet. Gynecol. 1970; 107: 124–32
   Google Scholar
• Gow S., MacGillivray I. Metabolic, hormonal and vascular changes after synthetic oestrogen therapy in oophorectomised women. Br. Med. J. 1971; 2: 73–7
   PubMed Web of Science ®Google Scholar
• Ajabor L. N., Tsai C. C., Vela P., Yen S. S.C. Effect of exogenous estrogen on carbohydrate metabolism in postmenopausal women. Am. J. Obstet. Gynecol. 1972; 113: 383–7
   Google Scholar
• Notelovitz M. Metabolic effect of conjugated oestrogens on glucose tolerance. S. Afr. Med. J. 1974; 48: 2599–603
   Google Scholar
• Notelovitz M. The effect of long-term oestrogen replacement therapy on glucose and lipid metabolism in post menopausal women. S. Afr. Med. J. 1976; 50, 2001–3
   Google Scholar
• Larsson-Cohn U., Wallentin L. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. Acta Endocrinol. 1977; 86: 583–96
   PubMedGoogle Scholar
• Thom M., Chakravarti S., Oram D., Studd J. Effect of hormone replacement therapy on glucose tolerance in postmenopausal women. Br. J. Obstet. Gynaecol. 1977; 84: 776–84
   Google Scholar
• Spellacy W., Buhi W., Birk S. The effects of two years of mestranol treatment on carbohydrate metabolism. Metabolism 1982; 31: 1006–8
   PubMed Web of Science ®Google Scholar
• Lindheim S. R., Presser S. C., Ditkoff E. C., Vijod M. A., Stanczyk F. Z., Lobo R. A. A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. Fertil. Steril. 1993; 60: 664–7
   PubMed Web of Science ®Google Scholar
• Lindheim S. R., Kojima T., Due D. M., Vijod M. A., Stanczyk F. Z., Lobo R. A. (1993) Insulin sensitivity is decreased in normal women by doses of ethinyl oestradiol used in oral contraceptives. Abstracts of the 41st Meeting of the Pacific Coast Fertility Society. 1993, A5
   Google Scholar
• Polderman K. H., Gooren L. J. G., Asscheman H., Bakker A., Heine R. J. Induction of insulin resistance by androgens and estrogens. J. Clin. Endocrinol. Metab. 1994; 79: 265–71
   PubMed Web of Science ®Google Scholar
• Godsland I., Walton C., Felton C., Prouder A., Patel A., Wynn V. Insulin resistance, secretion and metabolism in users of oral contraceptives. J. Clin. Endocrinol. Metab. 1992; 74: 64–70
   PubMed Web of Science ®Google Scholar
• Godsland I. F., Crook D. Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk. Am. J. Obstet. Cynecol. 1994; 70: 1528–36
   Google Scholar
• Burke C. Biologically active cortisol in plasma of oestrogen-treated and normal subjects. Br. Med. J. 1969; 2: 798–800
   PubMed Web of Science ®Google Scholar
• Doar J. W. H., Wynn V. Effects of obesity, glucocorticoid, and oral contraceptive therapy on plasma glucose and blood pyruvate levels. Br. Med. J. 1970; 1: 149–52
   PubMedGoogle Scholar
• Rose D. P., Adams P. W. Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone. J. Clin. Pathol. 1972; 25: 252–58
   PubMed Web of Science ®Google Scholar
• Adams P. W., Wynn V., Folkard J., Seed M. Influence of oral contraceptives, pyridoxine (vitamin B6), and tryptophan on carbohydrate metabolism. Lancet 1976; 1: 759–64
   Google Scholar
• Kalkhoff R., Jacobson M., Lemper D. Progesterone, pregnancy and the augmented plasma insulin response. J. Clin. Endocrinol. 1970; 31: 248
   Google Scholar
• Gershberg H., Zorrilla E., Hernandez A., Hulse M. Effects of medroxyprogesterone acetate on serum insulin and growth hormone levels in diabetics and potential diabetics. Obstet. Cynecol. 1969; 33: 383–9
   Google Scholar
• Spellacy W., McLeod A., Buhi W., Birk S., McCreary S. Medroxyprogesterone acetate and carbohydrate metabolism: measurement of glucose, insulin and growth hormone during six months' time. Fertil. Steril. 1970; 21: 457–63
   Google Scholar
• Spellacy W., McLeod A., Buhi W., Birk S. Depot medroxyprogesterone acetate and carbohydrate metabolism: measurement of glucose, insulin and growth hormone after twelve months' use. Fertil. Steril. 1972; 23: 239–44
   PubMed Web of Science ®Google Scholar
• Vermeulen A., Thiery M. Hormonal contraceptives and carbohydrate tolerance. II Influence of medroxyprogesterone acetate and chronic oral contraceptives. Diabetologia 1974; 10: 253–9
   Google Scholar
• Tuttle S., Turkington V. Effects of medroxyprogesterone acetate on carbohydrate metabolism. Obstet. Gynecol. 1974; 43: 685–92
   PubMedGoogle Scholar
• Spellacy W., Buhi W., Birk S. Norgestrel and carbohydrate-lipid metabolism: glucose, insulin and triglyceride changes during 6 months time of use. Contraception 1974; 9: 615–25
   Google Scholar
• Spellacy W., Buhi W., Birk S. The effects of norgestrel on carbohydrate and lipid metabolism over one year. Am. J. Obstet. Cynecol. 1976; 125: 984–6
   PubMed Web of Science ®Google Scholar
• Liew D. F.M., Ng C. S. A., Heng S. H., Ratnam S. S. A comparative study of the metabolic effects of injectable and oral contraceptives. Contraception 1986; 33: 385–94
   Google Scholar
• Singh K., Viegas O., Liew D., Singh P., Ratnam S. The effects of norplant-2 rods on clinical chemistry in Singaporean acceptors affer 1 year of use: metabolic changes. Contraception 1988; 38: 453–63
   PubMed Web of Science ®Google Scholar
• Godsland I., Crook D., Simpson R., Prouder T., Felton C., Lees B., Anyaoku V., Devenport M., Wynn V. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N. Engl. J. Med. 1990; 323: 1375–81
   PubMed Web of Science ®Google Scholar
• Konje J., Otolorin E., Lapido O. The effect of continuous subdermal levonorgestrel (Norplant) on carbohydrate metabolism. Am. J. Obstet. Gynecol. 1992; 66: 15–19
   Google Scholar
• Larsson-Cohn U., Tengstgrom B., Wide L. Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment. Acta Endocrinol. 1969; 62: 242–50
   Google Scholar
• Gilfirich H. J., Nieschlag E., Dudeck J., et al. Norethisterononanthat - untersuchungen wahrend der anwendung eines lang wirk enden parenteralen kontrazeptivum. Deutsch Med. Wochenschr. 1969; 94: 2474–7
   Google Scholar
• Beck P., Venable R., Hoff D. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives. J. Clin. Endocrinol. Metab. 1975; 41: 44–53
   Google Scholar
• Godsland I. F., Crook D., Devenport M., Wynn V. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception 1995; 52: 143–9
   PubMed Web of Science ®Google Scholar